These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18260053)

  • 1. [The need for pharmacology in vitreoretinal surgery SOE Lecture 2007].
    Gandorfer A
    Klin Monbl Augenheilkd; 2007 Dec; 224(12):900-4. PubMed ID: 18260053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective of pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():1-6. PubMed ID: 19494646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microplasmin for vitreomacular traction.
    Udaondo P; Diaz-Llopis M; Garcia-Delpech S; Salom D; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1859, 1859.e1; author reply 1859-60. PubMed ID: 20816250
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological vitrectomy.
    Tanaka M; Qui H
    Semin Ophthalmol; 2000 Mar; 15(1):51-61. PubMed ID: 10749315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological vitreolysis].
    Gandorfer A
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microplasmin-assisted vitrectomy.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():26-30. PubMed ID: 19494649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evaluation of microplasmin - an alternative to vital dyes.
    Gandorfer A
    Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of enzyme in vitreoretinal surgery].
    Czajka M; Pecold K
    Klin Oczna; 2002; 104(1):59-62. PubMed ID: 12046313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between vitrectomy and the morphology and function of the retina].
    Terasaki H
    Nippon Ganka Gakkai Zasshi; 2003 Dec; 107(12):836-64; discussion 865. PubMed ID: 14733133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy.
    Chen W; Mo W; Sun K; Huang X; Zhang YL; Song HY
    Curr Eye Res; 2009 Dec; 34(12):1057-64. PubMed ID: 19958125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable drug may help avoid eye surgery in patients with vitreomacular adhesion.
    Morrow T
    Manag Care; 2013 Jan; 22(1):49-50. PubMed ID: 23373143
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.
    Gandorfer A; Putz E; Welge-Lüssen U; Grüterich M; Ulbig M; Kampik A
    Br J Ophthalmol; 2001 Jan; 85(1):6-10. PubMed ID: 11133703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic vitreolysis.
    Rhéaume MA; Vavvas D
    Semin Ophthalmol; 2010; 25(5-6):295-302. PubMed ID: 21091015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic Vitrectomy and Pharmacologic Vitreodynamics.
    Shah AR; Trese MT
    Dev Ophthalmol; 2016; 55():357-64. PubMed ID: 26501959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of 23-gauge pars plana vitrectomy for pediatric vitreoretinal conditions.
    Singh R; Kumari N; Katoch D; Sanghi G; Gupta A; Dogra MR
    J Pediatr Ophthalmol Strabismus; 2014; 51(1):27-31. PubMed ID: 24297093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferative Vitreoretinopathy: Therapeutic Strategies].
    Schaub F; Enders P; Fauser S
    Klin Monbl Augenheilkd; 2016 Sep; 233(9):1016-23. PubMed ID: 27479579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
    Takkar B; Azad S
    Am J Ophthalmol; 2016 Apr; 164():145. PubMed ID: 26944755
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
    Masri I; Steel DH
    Am J Ophthalmol; 2016 Apr; 164():147-8. PubMed ID: 26883287
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.